chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Blood pressure increased, Bronchitis, COVID-19, Chest X-ray normal
Clinical narrative: Patient is a 78 y.o. male with PMH HTN, CKD, Prior CVA who presented from home on 7/21/2023 with generalized weakness due to COVID infection. He had a positive home test on 7/21, he subsequently was started on Paxlovid which he completed a total of 3 days. He remained stable on RA, not requiring Oxygen therapy or steroids. Hospitalization was further complicated by profound diarrhea and pt was tested and found positive for C-diff. Started him on PO Vancomycin x10 days, diarrhea slowly improving. PT/OT followed and recommended SNF.       COVID infection Acute Bronchitis - Presented with: frequent cough, weakness, and fevers;  (unable to get out of bed). Came to the hospital after recommendation from PCP - Symptom onset: 7/20/2023 - Positive COVID-19: 7/21/2023 at home kit, not tested on admit; positive family members as well   - Vaccination status: Vaccinated with Pfizer with last dose 11/2022 - CXR on admission showed non-acute  - Oxygen status: stable on RA  - Decadron: Does not qualify due to SpO2>94% on RA.  - Remdesivir: Does not qualify due to SpO2>94% on RA. - Completed 3 day course of Paxlovid - DVT prophylaxis:Lovenox - Serial COVID labs ordered: No - Case Management/Social Services consulted: Yes; PT/OT following with plan for SNF at DC - continue good pulmonary hygiene/IS    C-Diff  - pt reporting multiple days and episodes of watery diarrhea - tested positive for C-diff - started on PO Vancomycin x10 days     Hypertension - elevated  - home regimen includes Procardia, Coreg, Clonidine, losartan  - resume home regimen, with hold parameters     CKD Stage 3b - stable; 1.29  - Gentle iv fluids on admit - Avoid nephrotoxic meds as able    History of stroke with residual cognitive and balance deficits Secondary parkinsonism - One in 2017 and one  in 2021.  Has ambulatory dysfunction since then and top of that patient has parkinsonism. -Continue Sinemet, rivastigmine, aspirin and statin   Diabetes mellitus type 2 - A1c 6.4 -Diet controlled.  Previously on Tresiba, metformin which have discontinued. - start SSI, monitor and adjust as needed  - ADA diet at DC   History of PE Chronic right lower extremity DVT -Treated with anticoagulation in the past - Lovenox for vte proph while here Hemochromatosis - per history; Follows with Ohio State hematology - Phlebotomy in the past.  - monitor CBC daily    Anxiety/depression - Continue home dose Celexa and Wellbutrin   Vascular Dementia - Follows with Neurology - resume OP management    Generalized Weakness Reduced mobility, PTA - In setting of known Parkinson's, now exacerbated by Covid infection - At baseline he uses a walker and is able to go up stairs (bedroom on 2nd floor of house) -On day of admit, was unable to get out of bed by himself - PT/OT recommending SNF at DC
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: Clostridium difficile infection, Clostridium test positive, Condition aggravated, Cough, Diabetic diet
Clinical narrative: Patient is a 78 y.o. male with PMH HTN, CKD, Prior CVA who presented from home on 7/21/2023 with generalized weakness due to COVID infection. He had a positive home test on 7/21, he subsequently was started on Paxlovid which he completed a total of 3 days. He remained stable on RA, not requiring Oxygen therapy or steroids. Hospitalization was further complicated by profound diarrhea and pt was tested and found positive for C-diff. Started him on PO Vancomycin x10 days, diarrhea slowly improving. PT/OT followed and recommended SNF.       COVID infection Acute Bronchitis - Presented with: frequent cough, weakness, and fevers;  (unable to get out of bed). Came to the hospital after recommendation from PCP - Symptom onset: 7/20/2023 - Positive COVID-19: 7/21/2023 at home kit, not tested on admit; positive family members as well   - Vaccination status: Vaccinated with Pfizer with last dose 11/2022 - CXR on admission showed non-acute  - Oxygen status: stable on RA  - Decadron: Does not qualify due to SpO2>94% on RA.  - Remdesivir: Does not qualify due to SpO2>94% on RA. - Completed 3 day course of Paxlovid - DVT prophylaxis:Lovenox - Serial COVID labs ordered: No - Case Management/Social Services consulted: Yes; PT/OT following with plan for SNF at DC - continue good pulmonary hygiene/IS    C-Diff  - pt reporting multiple days and episodes of watery diarrhea - tested positive for C-diff - started on PO Vancomycin x10 days     Hypertension - elevated  - home regimen includes Procardia, Coreg, Clonidine, losartan  - resume home regimen, with hold parameters     CKD Stage 3b - stable; 1.29  - Gentle iv fluids on admit - Avoid nephrotoxic meds as able    History of stroke with residual cognitive and balance deficits Secondary parkinsonism - One in 2017 and one  in 2021.  Has ambulatory dysfunction since then and top of that patient has parkinsonism. -Continue Sinemet, rivastigmine, aspirin and statin   Diabetes mellitus type 2 - A1c 6.4 -Diet controlled.  Previously on Tresiba, metformin which have discontinued. - start SSI, monitor and adjust as needed  - ADA diet at DC   History of PE Chronic right lower extremity DVT -Treated with anticoagulation in the past - Lovenox for vte proph while here Hemochromatosis - per history; Follows with Ohio State hematology - Phlebotomy in the past.  - monitor CBC daily    Anxiety/depression - Continue home dose Celexa and Wellbutrin   Vascular Dementia - Follows with Neurology - resume OP management    Generalized Weakness Reduced mobility, PTA - In setting of known Parkinson's, now exacerbated by Covid infection - At baseline he uses a walker and is able to go up stairs (bedroom on 2nd floor of house) -On day of admit, was unable to get out of bed by himself - PT/OT recommending SNF at DC
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: Diarrhoea, Glycosylated haemoglobin normal, Mobility decreased, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient is a 78 y.o. male with PMH HTN, CKD, Prior CVA who presented from home on 7/21/2023 with generalized weakness due to COVID infection. He had a positive home test on 7/21, he subsequently was started on Paxlovid which he completed a total of 3 days. He remained stable on RA, not requiring Oxygen therapy or steroids. Hospitalization was further complicated by profound diarrhea and pt was tested and found positive for C-diff. Started him on PO Vancomycin x10 days, diarrhea slowly improving. PT/OT followed and recommended SNF.       COVID infection Acute Bronchitis - Presented with: frequent cough, weakness, and fevers;  (unable to get out of bed). Came to the hospital after recommendation from PCP - Symptom onset: 7/20/2023 - Positive COVID-19: 7/21/2023 at home kit, not tested on admit; positive family members as well   - Vaccination status: Vaccinated with Pfizer with last dose 11/2022 - CXR on admission showed non-acute  - Oxygen status: stable on RA  - Decadron: Does not qualify due to SpO2>94% on RA.  - Remdesivir: Does not qualify due to SpO2>94% on RA. - Completed 3 day course of Paxlovid - DVT prophylaxis:Lovenox - Serial COVID labs ordered: No - Case Management/Social Services consulted: Yes; PT/OT following with plan for SNF at DC - continue good pulmonary hygiene/IS    C-Diff  - pt reporting multiple days and episodes of watery diarrhea - tested positive for C-diff - started on PO Vancomycin x10 days     Hypertension - elevated  - home regimen includes Procardia, Coreg, Clonidine, losartan  - resume home regimen, with hold parameters     CKD Stage 3b - stable; 1.29  - Gentle iv fluids on admit - Avoid nephrotoxic meds as able    History of stroke with residual cognitive and balance deficits Secondary parkinsonism - One in 2017 and one  in 2021.  Has ambulatory dysfunction since then and top of that patient has parkinsonism. -Continue Sinemet, rivastigmine, aspirin and statin   Diabetes mellitus type 2 - A1c 6.4 -Diet controlled.  Previously on Tresiba, metformin which have discontinued. - start SSI, monitor and adjust as needed  - ADA diet at DC   History of PE Chronic right lower extremity DVT -Treated with anticoagulation in the past - Lovenox for vte proph while here Hemochromatosis - per history; Follows with Ohio State hematology - Phlebotomy in the past.  - monitor CBC daily    Anxiety/depression - Continue home dose Celexa and Wellbutrin   Vascular Dementia - Follows with Neurology - resume OP management    Generalized Weakness Reduced mobility, PTA - In setting of known Parkinson's, now exacerbated by Covid infection - At baseline he uses a walker and is able to go up stairs (bedroom on 2nd floor of house) -On day of admit, was unable to get out of bed by himself - PT/OT recommending SNF at DC
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Atrial fibrillation, Blood creatinine increased, Blood glucose normal, Blood urea increased
Clinical narrative: Patient is a 76 y.o. male patient, DO with history of atrial fibrillation, diabetes, CAD, hyperlipidemia, hypertension, and CKDIII presented with COVID.   Patient reports about 3 days of fatigue, poor appetite, nausea, diarrhea, and SOB.  Patient believes he had a couple of his COVID vaccines but it has been a while.  Patient does not recall a COPD history either and does not normally wear oxygen at home.   In the ED vitals are as follows, temperature 98.1, blood pressure 118/75, heart rate 97, RR 16, and oxygen saturation of 94% on 2L NC. Labs results were significant for creatinine 1.90, BUN 29, glucose 138. The rest of the CBC and CMP were within normal limits. Troponin 26-20. Flu swab negat   Patient is a 76 y.o. male patient, DO with history of atrial fibrillation, diabetes, CAD, hyperlipidemia, hypertension, and CKDIII presented with COVID.   Patient reports about 3 days of fatigue, poor appetite, nausea, diarrhea, and SOB.  Patient believes he had a couple of his COVID vaccines but it has been a while.  Patient does not recall a COPD history either and does not normally wear oxygen at home.   In the ED vitals are as follows, temperature 98.1, blood pressure 118/75, heart rate 97, RR 16, and oxygen saturation of 94% on 2L NC. Labs results were significant for creatinine 1.90, BUN 29, glucose 138. The rest of the CBC and CMP were within normal limits. Troponin 26-20. Flu swab negative. Chest x-ray showed no acute cardiopulmonary process. CT abdomen/pelvis showed diverticulosis, prostatic enlargement, small bilateral fat containing inguinal hernias, chronic bilateral L5 spondylolysis, diffuse demineralization, chronic mild height loss L5 vertebral body, small sliding type hiatal hernia, and mild bilateral renal cortical scarring. Patient was given dexamethasone and 1L NSS bolus. Patient admitted for observation.    Clinical Summary Patient's acute respiratory failure secondary to COVID improved with dexamethasone and remdesivir and was weaned to room air without oxygen requirement at discharge.  Patient's VS and labs were stable otherwise and patient will be discharged home with instructions to follow up with PCP.   Discharge diagnosis Acute respiratory failure secondary to COVID Persistent atrial fibrillation CAD Hyperlipidemia Hypertension Diabetes CKDIII
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Bone demineralisation, COVID-19, Chest X-ray normal, Computerised tomogram abdomen abnormal, Condition aggravated
Clinical narrative: Patient is a 76 y.o. male patient, DO with history of atrial fibrillation, diabetes, CAD, hyperlipidemia, hypertension, and CKDIII presented with COVID.   Patient reports about 3 days of fatigue, poor appetite, nausea, diarrhea, and SOB.  Patient believes he had a couple of his COVID vaccines but it has been a while.  Patient does not recall a COPD history either and does not normally wear oxygen at home.   In the ED vitals are as follows, temperature 98.1, blood pressure 118/75, heart rate 97, RR 16, and oxygen saturation of 94% on 2L NC. Labs results were significant for creatinine 1.90, BUN 29, glucose 138. The rest of the CBC and CMP were within normal limits. Troponin 26-20. Flu swab negat   Patient is a 76 y.o. male patient, DO with history of atrial fibrillation, diabetes, CAD, hyperlipidemia, hypertension, and CKDIII presented with COVID.   Patient reports about 3 days of fatigue, poor appetite, nausea, diarrhea, and SOB.  Patient believes he had a couple of his COVID vaccines but it has been a while.  Patient does not recall a COPD history either and does not normally wear oxygen at home.   In the ED vitals are as follows, temperature 98.1, blood pressure 118/75, heart rate 97, RR 16, and oxygen saturation of 94% on 2L NC. Labs results were significant for creatinine 1.90, BUN 29, glucose 138. The rest of the CBC and CMP were within normal limits. Troponin 26-20. Flu swab negative. Chest x-ray showed no acute cardiopulmonary process. CT abdomen/pelvis showed diverticulosis, prostatic enlargement, small bilateral fat containing inguinal hernias, chronic bilateral L5 spondylolysis, diffuse demineralization, chronic mild height loss L5 vertebral body, small sliding type hiatal hernia, and mild bilateral renal cortical scarring. Patient was given dexamethasone and 1L NSS bolus. Patient admitted for observation.    Clinical Summary Patient's acute respiratory failure secondary to COVID improved with dexamethasone and remdesivir and was weaned to room air without oxygen requirement at discharge.  Patient's VS and labs were stable otherwise and patient will be discharged home with instructions to follow up with PCP.   Discharge diagnosis Acute respiratory failure secondary to COVID Persistent atrial fibrillation CAD Hyperlipidemia Hypertension Diabetes CKDIII
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Diverticulum, Dyspnoea, Fatigue
Clinical narrative: Patient is a 76 y.o. male patient, DO with history of atrial fibrillation, diabetes, CAD, hyperlipidemia, hypertension, and CKDIII presented with COVID.   Patient reports about 3 days of fatigue, poor appetite, nausea, diarrhea, and SOB.  Patient believes he had a couple of his COVID vaccines but it has been a while.  Patient does not recall a COPD history either and does not normally wear oxygen at home.   In the ED vitals are as follows, temperature 98.1, blood pressure 118/75, heart rate 97, RR 16, and oxygen saturation of 94% on 2L NC. Labs results were significant for creatinine 1.90, BUN 29, glucose 138. The rest of the CBC and CMP were within normal limits. Troponin 26-20. Flu swab negat   Patient is a 76 y.o. male patient, DO with history of atrial fibrillation, diabetes, CAD, hyperlipidemia, hypertension, and CKDIII presented with COVID.   Patient reports about 3 days of fatigue, poor appetite, nausea, diarrhea, and SOB.  Patient believes he had a couple of his COVID vaccines but it has been a while.  Patient does not recall a COPD history either and does not normally wear oxygen at home.   In the ED vitals are as follows, temperature 98.1, blood pressure 118/75, heart rate 97, RR 16, and oxygen saturation of 94% on 2L NC. Labs results were significant for creatinine 1.90, BUN 29, glucose 138. The rest of the CBC and CMP were within normal limits. Troponin 26-20. Flu swab negative. Chest x-ray showed no acute cardiopulmonary process. CT abdomen/pelvis showed diverticulosis, prostatic enlargement, small bilateral fat containing inguinal hernias, chronic bilateral L5 spondylolysis, diffuse demineralization, chronic mild height loss L5 vertebral body, small sliding type hiatal hernia, and mild bilateral renal cortical scarring. Patient was given dexamethasone and 1L NSS bolus. Patient admitted for observation.    Clinical Summary Patient's acute respiratory failure secondary to COVID improved with dexamethasone and remdesivir and was weaned to room air without oxygen requirement at discharge.  Patient's VS and labs were stable otherwise and patient will be discharged home with instructions to follow up with PCP.   Discharge diagnosis Acute respiratory failure secondary to COVID Persistent atrial fibrillation CAD Hyperlipidemia Hypertension Diabetes CKDIII
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count normal, Hiatus hernia, Influenza virus test negative, Inguinal hernia, Intervertebral disc space narrowing
Clinical narrative: Patient is a 76 y.o. male patient, DO with history of atrial fibrillation, diabetes, CAD, hyperlipidemia, hypertension, and CKDIII presented with COVID.   Patient reports about 3 days of fatigue, poor appetite, nausea, diarrhea, and SOB.  Patient believes he had a couple of his COVID vaccines but it has been a while.  Patient does not recall a COPD history either and does not normally wear oxygen at home.   In the ED vitals are as follows, temperature 98.1, blood pressure 118/75, heart rate 97, RR 16, and oxygen saturation of 94% on 2L NC. Labs results were significant for creatinine 1.90, BUN 29, glucose 138. The rest of the CBC and CMP were within normal limits. Troponin 26-20. Flu swab negat   Patient is a 76 y.o. male patient, DO with history of atrial fibrillation, diabetes, CAD, hyperlipidemia, hypertension, and CKDIII presented with COVID.   Patient reports about 3 days of fatigue, poor appetite, nausea, diarrhea, and SOB.  Patient believes he had a couple of his COVID vaccines but it has been a while.  Patient does not recall a COPD history either and does not normally wear oxygen at home.   In the ED vitals are as follows, temperature 98.1, blood pressure 118/75, heart rate 97, RR 16, and oxygen saturation of 94% on 2L NC. Labs results were significant for creatinine 1.90, BUN 29, glucose 138. The rest of the CBC and CMP were within normal limits. Troponin 26-20. Flu swab negative. Chest x-ray showed no acute cardiopulmonary process. CT abdomen/pelvis showed diverticulosis, prostatic enlargement, small bilateral fat containing inguinal hernias, chronic bilateral L5 spondylolysis, diffuse demineralization, chronic mild height loss L5 vertebral body, small sliding type hiatal hernia, and mild bilateral renal cortical scarring. Patient was given dexamethasone and 1L NSS bolus. Patient admitted for observation.    Clinical Summary Patient's acute respiratory failure secondary to COVID improved with dexamethasone and remdesivir and was weaned to room air without oxygen requirement at discharge.  Patient's VS and labs were stable otherwise and patient will be discharged home with instructions to follow up with PCP.   Discharge diagnosis Acute respiratory failure secondary to COVID Persistent atrial fibrillation CAD Hyperlipidemia Hypertension Diabetes CKDIII
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Kidney fibrosis, Laboratory test abnormal, Metabolic function test normal, Nausea, Prostatomegaly
Clinical narrative: Patient is a 76 y.o. male patient, DO with history of atrial fibrillation, diabetes, CAD, hyperlipidemia, hypertension, and CKDIII presented with COVID.   Patient reports about 3 days of fatigue, poor appetite, nausea, diarrhea, and SOB.  Patient believes he had a couple of his COVID vaccines but it has been a while.  Patient does not recall a COPD history either and does not normally wear oxygen at home.   In the ED vitals are as follows, temperature 98.1, blood pressure 118/75, heart rate 97, RR 16, and oxygen saturation of 94% on 2L NC. Labs results were significant for creatinine 1.90, BUN 29, glucose 138. The rest of the CBC and CMP were within normal limits. Troponin 26-20. Flu swab negat   Patient is a 76 y.o. male patient, DO with history of atrial fibrillation, diabetes, CAD, hyperlipidemia, hypertension, and CKDIII presented with COVID.   Patient reports about 3 days of fatigue, poor appetite, nausea, diarrhea, and SOB.  Patient believes he had a couple of his COVID vaccines but it has been a while.  Patient does not recall a COPD history either and does not normally wear oxygen at home.   In the ED vitals are as follows, temperature 98.1, blood pressure 118/75, heart rate 97, RR 16, and oxygen saturation of 94% on 2L NC. Labs results were significant for creatinine 1.90, BUN 29, glucose 138. The rest of the CBC and CMP were within normal limits. Troponin 26-20. Flu swab negative. Chest x-ray showed no acute cardiopulmonary process. CT abdomen/pelvis showed diverticulosis, prostatic enlargement, small bilateral fat containing inguinal hernias, chronic bilateral L5 spondylolysis, diffuse demineralization, chronic mild height loss L5 vertebral body, small sliding type hiatal hernia, and mild bilateral renal cortical scarring. Patient was given dexamethasone and 1L NSS bolus. Patient admitted for observation.    Clinical Summary Patient's acute respiratory failure secondary to COVID improved with dexamethasone and remdesivir and was weaned to room air without oxygen requirement at discharge.  Patient's VS and labs were stable otherwise and patient will be discharged home with instructions to follow up with PCP.   Discharge diagnosis Acute respiratory failure secondary to COVID Persistent atrial fibrillation CAD Hyperlipidemia Hypertension Diabetes CKDIII
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Spondylolysis, Troponin increased
Clinical narrative: Patient is a 76 y.o. male patient, DO with history of atrial fibrillation, diabetes, CAD, hyperlipidemia, hypertension, and CKDIII presented with COVID.   Patient reports about 3 days of fatigue, poor appetite, nausea, diarrhea, and SOB.  Patient believes he had a couple of his COVID vaccines but it has been a while.  Patient does not recall a COPD history either and does not normally wear oxygen at home.   In the ED vitals are as follows, temperature 98.1, blood pressure 118/75, heart rate 97, RR 16, and oxygen saturation of 94% on 2L NC. Labs results were significant for creatinine 1.90, BUN 29, glucose 138. The rest of the CBC and CMP were within normal limits. Troponin 26-20. Flu swab negat   Patient is a 76 y.o. male patient, DO with history of atrial fibrillation, diabetes, CAD, hyperlipidemia, hypertension, and CKDIII presented with COVID.   Patient reports about 3 days of fatigue, poor appetite, nausea, diarrhea, and SOB.  Patient believes he had a couple of his COVID vaccines but it has been a while.  Patient does not recall a COPD history either and does not normally wear oxygen at home.   In the ED vitals are as follows, temperature 98.1, blood pressure 118/75, heart rate 97, RR 16, and oxygen saturation of 94% on 2L NC. Labs results were significant for creatinine 1.90, BUN 29, glucose 138. The rest of the CBC and CMP were within normal limits. Troponin 26-20. Flu swab negative. Chest x-ray showed no acute cardiopulmonary process. CT abdomen/pelvis showed diverticulosis, prostatic enlargement, small bilateral fat containing inguinal hernias, chronic bilateral L5 spondylolysis, diffuse demineralization, chronic mild height loss L5 vertebral body, small sliding type hiatal hernia, and mild bilateral renal cortical scarring. Patient was given dexamethasone and 1L NSS bolus. Patient admitted for observation.    Clinical Summary Patient's acute respiratory failure secondary to COVID improved with dexamethasone and remdesivir and was weaned to room air without oxygen requirement at discharge.  Patient's VS and labs were stable otherwise and patient will be discharged home with instructions to follow up with PCP.   Discharge diagnosis Acute respiratory failure secondary to COVID Persistent atrial fibrillation CAD Hyperlipidemia Hypertension Diabetes CKDIII
Age: 88.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, COVID-19, Condition aggravated, Dyspnoea, Exposure to SARS-CoV-2
Clinical narrative: Patient is a 88 y.o. female patient of, MD with a history of cough   Discharge Diagnoses: Covid 19    Acute on chronic hypoxic respiratory failure              - baseline 2 L NC  Chronic Hyponatremia             - baseline around 129  Metabolic encephalopathy             - previous history of same; previous admissions with full neurology evaluation  HTN COPD Overweight; POA BMI 35  Emphysema    Patient presented to Hospital with SOB, AMS. Has known history of encephalopathy and hyponatremia noted on previous admissions. Currently stays at facility and roommate was + for Covid. Patient also noted to be Covid +; has had vaccinations and booster. Initially required Bipap from ED; deescalated to her ba  Patient is a 88 y.o. female patient of, MD with a history of cough   Discharge Diagnoses: Covid 19    Acute on chronic hypoxic respiratory failure              - baseline 2 L NC  Chronic Hyponatremia             - baseline around 129  Metabolic encephalopathy             - previous history of same; previous admissions with full neurology evaluation  HTN COPD Overweight; POA BMI 35  Emphysema    Patient presented to Hospital with SOB, AMS. Has known history of encephalopathy and hyponatremia noted on previous admissions. Currently stays at facility and roommate was + for Covid. Patient also noted to be Covid +; has had vaccinations and booster. Initially required Bipap from ED; deescalated to her baseline 2 L NC; pulmonary evaluated patient and recommended 10 day course of 6 mg Decadron. Patient will return to facility
Age: 88.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hyponatraemia, Mental status changes, Metabolic encephalopathy, Positive airway pressure therapy, Respiratory failure
Clinical narrative: Patient is a 88 y.o. female patient of, MD with a history of cough   Discharge Diagnoses: Covid 19    Acute on chronic hypoxic respiratory failure              - baseline 2 L NC  Chronic Hyponatremia             - baseline around 129  Metabolic encephalopathy             - previous history of same; previous admissions with full neurology evaluation  HTN COPD Overweight; POA BMI 35  Emphysema    Patient presented to Hospital with SOB, AMS. Has known history of encephalopathy and hyponatremia noted on previous admissions. Currently stays at facility and roommate was + for Covid. Patient also noted to be Covid +; has had vaccinations and booster. Initially required Bipap from ED; deescalated to her ba  Patient is a 88 y.o. female patient of, MD with a history of cough   Discharge Diagnoses: Covid 19    Acute on chronic hypoxic respiratory failure              - baseline 2 L NC  Chronic Hyponatremia             - baseline around 129  Metabolic encephalopathy             - previous history of same; previous admissions with full neurology evaluation  HTN COPD Overweight; POA BMI 35  Emphysema    Patient presented to Hospital with SOB, AMS. Has known history of encephalopathy and hyponatremia noted on previous admissions. Currently stays at facility and roommate was + for Covid. Patient also noted to be Covid +; has had vaccinations and booster. Initially required Bipap from ED; deescalated to her baseline 2 L NC; pulmonary evaluated patient and recommended 10 day course of 6 mg Decadron. Patient will return to facility
Age: 88.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient is a 88 y.o. female patient of, MD with a history of cough   Discharge Diagnoses: Covid 19    Acute on chronic hypoxic respiratory failure              - baseline 2 L NC  Chronic Hyponatremia             - baseline around 129  Metabolic encephalopathy             - previous history of same; previous admissions with full neurology evaluation  HTN COPD Overweight; POA BMI 35  Emphysema    Patient presented to Hospital with SOB, AMS. Has known history of encephalopathy and hyponatremia noted on previous admissions. Currently stays at facility and roommate was + for Covid. Patient also noted to be Covid +; has had vaccinations and booster. Initially required Bipap from ED; deescalated to her ba  Patient is a 88 y.o. female patient of, MD with a history of cough   Discharge Diagnoses: Covid 19    Acute on chronic hypoxic respiratory failure              - baseline 2 L NC  Chronic Hyponatremia             - baseline around 129  Metabolic encephalopathy             - previous history of same; previous admissions with full neurology evaluation  HTN COPD Overweight; POA BMI 35  Emphysema    Patient presented to Hospital with SOB, AMS. Has known history of encephalopathy and hyponatremia noted on previous admissions. Currently stays at facility and roommate was + for Covid. Patient also noted to be Covid +; has had vaccinations and booster. Initially required Bipap from ED; deescalated to her baseline 2 L NC; pulmonary evaluated patient and recommended 10 day course of 6 mg Decadron. Patient will return to facility
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Extra dose administered
Clinical narrative: Patient was given unnecessary second dose of the Tdap  & Menevo  vaccine off schedule. The patient's father was unaware that the patient had vaccine in another facility until technician checked state record.
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Confusional state, Intensive care, Respiratory distress, Rhabdomyolysis
Clinical narrative: Within 72 hours of vaccination, she developed rhabdomyolysis, confusion, and respiratory distress
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 25.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error, Wrong product administered
Clinical narrative: Vial was initially stored in the refrigerator on 22-JUN-2023 and administered to patient on 03-AUG-2023; No adverse event; patient received an expired first dose; 25-year-old patient received an expired first dose Bivalent Moderna COVID-19 vaccine on 03-AUG-2023; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received an expired first dose), WRONG PRODUCT ADMINISTERED (25-year-old patient received an expired first dose Bivalent Moderna COVID-19 vaccine on 03-AUG-2023), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 22-JUN-2023 and administered to patient on 03-AUG-2023) and NO ADVERSE EVENT (No adverse event) in a 25-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7642B) for COVID-19 prophylaxis.     No medical history information were reported by the reporter.  Concomitant products included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DTAP), MEASLES VACCINE (MEASLES), VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) and HEPATITIS B VACCINE (HEP B VAX) for an unknown indication.    On 03-Aug-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 03-Aug-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received an expired first dose) and WRONG PRODUCT ADMINISTERED (25-year-old patient received an expired first dose Bivalent Moderna COVID-19 vaccine on 03-AUG-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 22-JUN-2023 and administered to patient on 03-AUG-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received an expired first dose), WRONG PRODUCT ADMINISTERED (25-year-old patient received an expired first dose Bivalent Moderna COVID-19 vaccine on 03-AUG-2023), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 22-JUN-2023 and administered to patient on 03-AUG-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient received an expired first dose), WRONG PRODUCT ADMINISTERED (25-year-old patient received an expired first dose Bivalent Moderna COVID-19 vaccine on 03-AUG-2023) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 22-JUN-2023 and administered to patient on 03-AUG-2023).    Patient received other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment details was not reported by the reporter.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 0.5
Sex: M
Vaccine: DTPPVHBHPB, PNC15, RV5, DTPPVHBHPB, PNC15, RV5
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient received first dose of Rotateq at 6 months (vaccine 8/2/2023). Merck notified for alternative vaccine schedule recommendations. No harm noted.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 58.0
Sex: M
Vaccine: COVID19-2
Symptoms: Injected limb mobility decreased, Injection site pain, Pain
Clinical narrative: Severe deltoid pain followed by restrictive and painful left shoulder movement now with significant sore muscles upper arm and shoulder
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea
Clinical narrative: Hospitalization for shortness of breath with COVID-19 on dates 7/24/2023- 8/2/2023.  Treated with dexamethasone, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 32.0
Sex: F
Vaccine: TD
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Td vaccine given on 7/11/23 as part of patient's annual work physical. Call received on 8/4/23 from patient's employer stating patient has been experiencing arm pain and slight impairment to range of motion since the vaccination.  Contacted provider for treatment recommendations. Provider suspects inflammation reaction and recommends  OTC ibuprofen or aleve for 7-10 days and applying ice for swelling.  Attempted to contact patient to convey treatment recommendations. Left voicemail and sent message through EHR.  Patient states she has been taking ibuprofen daily since the vaccination with no improvement.  Provider recommends follow-up with primary care provider or urgent care.
Age: 14.0
Sex: F
Vaccine: HEPA
Symptoms: Incorrect dose administered
Clinical narrative: pt given and adult dose of Havrix (Hep A)
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid Infection
Age: 36.0
Sex: M
Vaccine: TD
Symptoms: Pain
Clinical narrative: Patient received Td vaccination on 7/20/2023 as part of his annual work physical.  Call received from employer on 8/4/2023 stating that patient is still experiencing mild arm pain.  Contacted provider for treatment recommendation. Provider recommends OTC ibuprofen or aleve for 7-10 days.  Attempted to contact patient to provide treatment recommendation. Unable to reach patient and unable to leave voicemail due to full inbox. Sent message to patient through EHR.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Chronic obstructive pulmonary disease, Condition aggravated, Respiratory failure
Clinical narrative: Hospitalization for acute exacerbation of COPD, Acute hypercapnic respiratory failure, COVID positive on dates 7/25/2023- 7/30/2023. Treated with dexamethasone, baricitinib, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Hospitalization for acute exacerbation of COPD, Acute hypercapnic respiratory failure, COVID positive on dates 7/25/2023- 7/30/2023. Treated with dexamethasone, baricitinib, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA
Age: 1.58
Sex: F
Vaccine: DTAPIPV, HEPA
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Pt was inadvertently given a Kinrix instead of a Hep A at 19 months of age. No signs or symptoms of reaction after injection was given. Parent was contacted and returned for Hep A in opposite thigh.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Acute coronary syndrome
Clinical narrative: ACUTE CORONARY SYNDROME, UNSPECIFIED
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Mobility decreased, Muscular weakness, Pain, Pain in extremity
Clinical narrative: Started out with a painful arm with weakness in affected arm to the point of difficulty in using affected arm. This lasted about a week. Then patient started experiencing a deep throbbing pain in the joints of all the patient's fingers but not affecting her wrists. This event is also present in her knees and ankles. This event is still ongoing. PCP seen advised patient to take OTC Ibuprofen TID PRN.
Age: 2.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: physician ordered moderna 6m-5y booster, moderna 6-11y booster was given
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Respiratory failure
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 0.75
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; administer the wrong vial and dosage twice to a younger patient as their 1st and 2nd dose; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (administer the wrong vial and dosage twice to a younger patient as their 1st and 2nd dose) and NO ADVERSE EVENT (No adverse event) in a 9-month-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     HCP did not describe Medical History or Condition.    On 06-Jun-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .2 milliliter. On 03-Jul-2023, received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to .2 milliliter. In 2023, the patient experienced WRONG PRODUCT ADMINISTERED (administer the wrong vial and dosage twice to a younger patient as their 1st and 2nd dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (administer the wrong vial and dosage twice to a younger patient as their 1st and 2nd dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (administer the wrong vial and dosage twice to a younger patient as their 1st and 2nd dose).    Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Concomitant medication not reported.   HCP reported that they administer the wrong vial and dosage twice to a younger patient as their 1st and 2nd dose. They were supposed to administer the Dark Blue Cap and Label with Gray Border. Patient received 0.2 ml dose of the Dark Pink Cap and Label with Yellow Box as a 1st dose on 06 Jun 2023 and as a 2nd dose on 03 Jul 2023. HCP stated she had initially reported to the CDPH here after the first dose. Patient was 9 months. Patient never received the Dark Blue Cap and Label with Gray Border.   Treatment medication not reported.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris
Clinical narrative: ANGINA, UNSPECIFIED
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Polyneuropathy
Clinical narrative: POLYNEUROPATHY ACUTE RESPIRATORY FAILURE
Age: 0.83
Sex: F
Vaccine: DTPPVHBHPB, PNC13, DTPPVHBHPB, PNC13
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Mobility decreased
Clinical narrative: Parent reported redness and swelling that grew quickly and wrapped around her left thigh. It was tender, hot to the touch, patient would not crawl and "wailed in pain"  Message was sent to the provider Dr. and they were advised to get seen in urgent care, support care suggested (ibuprofen)
Age: 0.83
Sex: F
Vaccine: DTPPVHBHPB, PNC13, DTPPVHBHPB, PNC13
Symptoms: Pain
Clinical narrative: Parent reported redness and swelling that grew quickly and wrapped around her left thigh. It was tender, hot to the touch, patient would not crawl and "wailed in pain"  Message was sent to the provider Dr. and they were advised to get seen in urgent care, support care suggested (ibuprofen)
Age: 0.83
Sex: F
Vaccine: DTPPVHBHPB, PNC13, DTPPVHBHPB, PNC13
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Parent reported redness and swelling that grew quickly and wrapped around her left thigh. It was tender, hot to the touch, patient would not crawl and "wailed in pain"  Message was sent to the provider Dr. and they were advised to get seen in urgent care, support care suggested (ibuprofen)
Age: 18.0
Sex: M
Vaccine: HEPA
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Hep A vaccine was administered. Patient however received the adult dose which shouldn't be administered until patient is 19 years of age or older. Patient is only 18 years old. Contacted Merck and report issue.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Symptom recurrence
Clinical narrative: ACUTE RESPIRATORY FAILURE 1/30/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 19.0
Sex: F
Vaccine: MMR
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: MMR was given to patient.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Somnolence
Clinical narrative: Major nausea, headaches, drowsiness
Age: 1.75
Sex: M
Vaccine: DTAPIPV
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Patient was administered Kinrix in error which is not recommended for this age group. Parents were made aware. Patient was asymptomatic.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 0.67
Sex: F
Vaccine: HIBV
Symptoms: Expired product administered
Clinical narrative: Administered expired vaccine. Parent opting not to revaccinate despite recommendations.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Deep vein thrombosis, Hypotension, Symptom recurrence
Clinical narrative: ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN HYPOTENSION ACUTE RESPIRATORY FAILURE 1/17/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Sex: U
Vaccine: COVID19
Symptoms: Coagulopathy, Urticaria
Clinical narrative: clotting; welts; This spontaneous case was reported by a consumer and describes the occurrence of COAGULOPATHY (clotting) and URTICARIA (welts) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer vaccine and Pfizer vaccine. Past adverse reactions to the above products included No adverse event with Pfizer vaccine and Pfizer vaccine.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced COAGULOPATHY (clotting) and URTICARIA (welts). At the time of the report, COAGULOPATHY (clotting) and URTICARIA (welts) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details not reported by the reporter. Dosage text was reported as Unknown. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-735551, US-MODERNATX, INC.-MOD-2023-735554, US-MODERNATX, INC.-MOD-2023-735567 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735551:Same reporter US-MODERNATX, INC.-MOD-2023-735554:Same reporter US-MODERNATX, INC.-MOD-2023-735567:Same reporter
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: ALLERGIC REACTION, INIT
Age: 82.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash, Rash erythematous, Rash papular, Swelling
Clinical narrative: Swollen and large red raised and extremely sore rash, approximately 4-5 inches.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Obstructive sleep apnoea syndrome, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE OBSTRUCTIVE SLEEP APNEA HYPOTENSION 8/23/2022 &  1/19/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Hyperhidrosis, Myalgia, Throat tightness, Tremor, Vomiting
Clinical narrative: Sweats, body shakes, vomiting, muscle pain, and tightness in throat starting at 9:00pm on 8/7/23 that lasted for about 5 hours per patient. Patient did not seek medical attention and is feeling fine right now.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Carotid artery occlusion, Computerised tomogram, Computerised tomogram heart, Muscular weakness
Clinical narrative: Three days after taking my second dose of Pfizer COVID 19 vaccine, I experienced a transient ischemic attack (TIA), with a temporary loss of control of my left arm and weakness in my left leg.  Following an emergency room visit and related testing it was determined that I had a 65% blockage of my right carotid artery.  I was given blood thinner and was hospitalized for three days.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal disorder, Transient ischaemic attack
Clinical narrative: Three days after taking my second dose of Pfizer COVID 19 vaccine, I experienced a transient ischemic attack (TIA), with a temporary loss of control of my left arm and weakness in my left leg.  Following an emergency room visit and related testing it was determined that I had a 65% blockage of my right carotid artery.  I was given blood thinner and was hospitalized for three days.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Extra dose administered, No adverse event
Clinical narrative: client presented for 12th grade school required meningococcal vaccine.  Nurse was given immunization encounter without a list of previous vaccines received by client and gave the requested meningococcal vaccine.  After the vaccine was given, the clerk gave the immunization print out to the nurse and it was discovered the client had the vaccine 6/2022 and did not need the vaccine given today.  No reaction to vaccine noted.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Sleep apnoea syndrome
Clinical narrative: SLEEP APNEA HYPOXIA
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Epilepsy
Clinical narrative: EPILEPSY, UNSPECIFIED
Age: 77.0
Sex: F
Vaccine: TDAP
Symptoms: No adverse event
Clinical narrative: There were no adverse affects or events.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Thrombotic stroke
Clinical narrative: ACUTE STROKE DUE TO THROMBOSIS OF UNSPECIFIED ARTERY
Age: 54.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Erythema, Injection site discharge, Injection site reaction, Skin warm
Clinical narrative: Patient developed a bubble at injection site which then fluid leaked out of.. Patient came to office on 8/8/23 and still had red flat area that was warm and most likely cellultis so antibiotics were prescribed